newsfilter
← Latest News
GlobeNewswire·

New Preclinical Data at SITC 2021 Show Broad Potential Utility of Codiak's Engineered Exosomes

– exoSTING™ monotherapy suppressed tumor growth and improved overall survival in a preclinical model of leptomeningeal disease, an aggressive metastasis of cancer to the central nervous system – – Combination of exoSTING™ and exoIL-12™ gen